Atherosclerosis: Clinical Trials

180 trials for Atherosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

113 completed, 33 unknown, 12 terminated, 8 recruiting. 180 Phase 1, 63 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1180Completed 113, Unknown 33, Terminated 12, Recruiting 8, Withdrawn 8, Not yet recruiting 4, Active not recruiting 2
Phase 263Completed 33, Unknown 18, Recruiting 3, Terminated 3, Withdrawn 3, Not yet recruiting 2, Active not recruiting 1

Follow Atherosclerosis: new trials by email Literature Review of Atherosclerosis trials Research Report on Atherosclerosis

Trials (filtered) newest first · largest first

All 180 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions
Test Drug, Reference Drug - Peripheral Arterial Disease
Phase 1Not yet recruitingAJU Pharm Co., Ltd.402026-11-012026-10-28
A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
STX-1150 - Elevated LDL-C and High Cholesterol
Phase 1RecruitingMonash University642026-06-302026-09-21
A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
CSL300, Placebo - End Stage Kidney Disease (ESKD)
Phase 1RecruitingCSL Behring242026-06-172026-07-07
Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia
CELULAS TRONCO, CONVENTIONAL DRESSING - Peripheral Arterial Disease, Leg Ulcer
Phase 1 / Phase 2Not yet recruitingUPECLIN HC FM Botucatu Unesp402026-06-012026-05-06
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
CG-0255 Besylate for Injection, CG-0255 Besylate Capsule, Clopidogrel - Acute Coronary Syndromes (ACS), Recent Myocardial Infarction
Phase 1RecruitingShanghai CureGene Pharmaceutical Co., Ltd.1362026-06-012026-06-29
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
TB-500, Placebo - Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
Phase 1 / Phase 2RecruitingHudson Biotech802026-02-052026-11-12
A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease
Yiyang Huoluo Decoction, conventional western medicine treatment - Coronary Heart Disease, Coronary Artery Disease
Phase 1 / Phase 2RecruitingXia Liang302026-01-162026-03-25
Fish Oil, Metformin and Heart Health in PCOS
Fish oil, Metformin, Fish Oil and Metformin - PCOS, Cardiovascular Disease
Phase 1RecruitingUniversity of Alberta1462025-11-012025-12-12
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
Carnosine - Peripheral Arterial Disease
Phase 1 / Phase 2RecruitingShahid Baba1442025-05-202025-05-29
A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity
AZD4144, Placebo - Healthy Participants
Phase 1CompletedAstraZeneca282025-04-222025-10-07
Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia.
Adipose tissue derived mesenchymal Stroma/stem Cells transplantation - Critical Limb Ischemia
Phase 1Not yet recruitingUniversity Hospital, Toulouse102025-01-012025-01-28
A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.
AZD4144, Placebo - Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease
Phase 1CompletedAstraZeneca292024-12-092025-11-25
Effect of Single-versus Double-limb Cycling Exercise on Blood Flow in Patients With Peripheral Artery Disease
Cycle - Peripheral Arterial Disease
Phase 1 / Phase 2UnknownCairo University752024-07-012024-07-24
Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia
EPCs, Clinical standard treatment (CST) - Critical Limb Ischemia
Phase 1UnknownAllife Medical Science and Technology Co., Ltd.272024-04-012024-04-11
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
Cilostazol Tablet 100 mg, PMR Tablet 145 mg - Intermittent Claudication
Phase 1CompletedGenovate Biotechnology Co., Ltd.,402023-11-282024-02-23
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
YN001, Placebo for YN001, rosuvastatin calcium tablets - Atherosclerotic Cardiovascular Disease
Phase 1 / Phase 2CompletedBeijing Inno Medicine Co., Ltd.1442023-10-082026-09-22
A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease
Home-based leg heat therapy - Peripheral Arterial Disease, Intermittent Claudication
Phase 1CompletedPurdue University62023-05-302025-08-15
Carnosine for Peripheral Arterial Disease Patients
Carnosine - Peripheral Arterial Disease
Phase 1 / Phase 2UnknownShahid Baba202023-03-012024-07-22
NAD Supplementation and Vascular Health in PAD
Nicotinamide riboside - Peripheral Artery Disease
Phase 1 / Phase 2CompletedUniversity of Oklahoma82023-02-272026-04-06

Showing 20 of 180. Sign in to see all of them.

Narrower conditions

Peripheral Arterial Disease (78)  ·  Chronic Limb-Threatening Ischemia (49)  ·  Peripheral Vascular Diseases (25)  ·  Intermittent Claudication (21)  ·  Cardiovascular Diseases (16)  ·  Inflammation (10)  ·  Hypercholesterolemia (8)  ·  Diabetes Mellitus (7)  ·  Ischemia (6)  ·  Vascular Diseases (6)  ·  Arterial Occlusive Diseases (5)  ·  Coronary Artery Disease (5)  ·  Diabetic Foot (5)  ·  Hypertension (5)

Broader conditions

Arteriosclerosis (177)  ·  Arterial Occlusive Diseases (175)  ·  Vascular Diseases (174)  ·  Cardiovascular Diseases (164)  ·  Pathological Conditions, Signs and Symptoms (90)  ·  Peripheral Vascular Diseases (87)  ·  Pathologic Processes (67)  ·  Disease Attributes (54)  ·  Chronic Disease (53)  ·  Ischemia (48)  ·  Peripheral Arterial Disease (34)  ·  Signs and Symptoms (25)  ·  Nutritional and Metabolic Diseases (22)  ·  Metabolic Diseases (20)

Interventions

darapladib (13)  ·  Cilostazol (6)  ·  Atorvastatin (3)  ·  Rosuvastatin Calcium (3)  ·  Saline Solution (3)  ·  Standard of Care (3)  ·  cholesterol-binding protein (3)  ·  rilapladib (3)  ·  6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide (2)  ·  Carnosine (2)  ·  Cell- and Tissue-Based Therapy (2)  ·  Clopidogrel (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Lipectomy (2)  ·  Sodium Chloride (2)

Sponsors

GlaxoSmithKline (19)  ·  National Heart, Lung, and Blood Institute (NHLBI) (6)  ·  Genovate Biotechnology Co., Ltd., (5)  ·  Losordo, Douglas, M.D. (4)  ·  Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (3)  ·  Bristol-Myers Squibb (3)  ·  First Affiliated Hospital of Harbin Medical University (3)  ·  MedImmune LLC (3)  ·  Proteon Therapeutics (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Ajou University School of Medicine (2)  ·  Alucent Biomedical (2)  ·  AstraZeneca (2)  ·  Heinrich-Heine University, Duesseldorf (2)  ·  Hoffmann-La Roche (2)

Countries

United States (86)  ·  China (14)  ·  Germany (10)  ·  Netherlands (6)  ·  South Korea (6)  ·  United Kingdom (6)  ·  Australia (5)  ·  Canada (5)  ·  India (5)  ·  Israel (4)  ·  Italy (4)  ·  Russia (4)  ·  Brazil (3)  ·  France (3)  ·  Japan (3)

Top investigators

Michael P Murphy, MD (3)  ·  Doo-Yeoun Cho, MD (2)  ·  Heng-yan Qu (2)  ·  Santiago A Garcia, MD (2)  ·  Abdalla Awidi, MD (1)  ·  Alexander Kharlamov, M.D., Ph.D. (1)  ·  Alexander Reyzelman, MD (1)  ·  Alisha Oropallo, MD (1)  ·  Allan Gordon, MD, PhD (1)  ·  Allan H Ropper, M.D. (1)  ·  Amir Lerman, MD (1)

Results publications

PMID 35802393, PMID 24475026, PMID 42573020, PMID 10777236, PMID 10805617, PMID 11581152, PMID 12473676, PMID 15324521, PMID 16449620, PMID 17223489, PMID 17353883, PMID 18779447, PMID 18783958, PMID 19050436, PMID 1917239, PMID 19301723, PMID 19711453, PMID 20097752, PMID 20832596, PMID 20940249, PMID 21160056, PMID 21594960, PMID 21901641, PMID 22003000, PMID 22020113, PMID 22145843, PMID 22852051, PMID 22875949, PMID 22877866, PMID 23192920, PMID 23278227, PMID 23375329, PMID 23670612, PMID 23727083, PMID 23758736, PMID 23797811, PMID 23899755, PMID 24070911, PMID 24218170, PMID 24333045, PMID 24456716, PMID 24552184, PMID 24613691, PMID 24650395, PMID 24990275, PMID 25239491, PMID 25287762, PMID 25567765, PMID 25578927, PMID 25908725

NIH funding

2009 (3), 2008 (1), 2023 (1), P01AT002034 (1), P01HL059407 (1), R01HL163419 (1), R21AG048001 (1)